Editorial Conflict of Interest Disclosure
(as of May 2024)
As part of good publication practices, all editors of the JAFES (Editor-in-Chief, Vice Editor-in-Chief, Associate Editors, Editorial Board and Advisers) are required to disclose on an annual basis, any potential conflict of interest, including current or recent financial relationships with any commercial entity whose products or services may be contained in the journal content. Disclosure represents a commitment to transparency and does not necessarily indicate a bias. This policy follows the recommendations of the International Committee of Medical Journal Editors (ICMJE) and the Committee on Publication Ethics (COPE).
The following were disclosed:
ELIZABETH PAZ-PACHECO | Editor-in-Chief | Prof. Pacheco receives grants for Metabolomics of DM Nephropathy from the Philippine Council for Health Research Development. She is a Past President of the Philippine College of Endocrinology, Diabetes and Metabolism (PCEDM).
CECILIA A. JIMENO | Vice Editor-in-Chief | Prof. Jimeno receives honoraria for lectures from Glaxo Smith Kline, Sanofi Aventis, Menarini, Merck and Novo Nordisk. She receives travel grants for CME from Corbridge and Sanofi Aventis.
GABRIEL V. JASUL JR. | Associate Editor | Prof. Jasul received honoraria for lectures from Sanofi Aventis, Novo Nordisk, MSD, Boehringer Ingelheim, Abbott Nutrition, AstraZeneca, LRI- Therapharma, UMed and Woerwag.
MADE RATNA SARASWATI | Associate Editor | Prof. Saraswati receives honoraria for lectures from Merck, Zuellig Pharma Therapeutics, Kalventis Sinergi Farma and Novo Nordisk.
NORLAILA MUSTAFA | Associate Editor | Prof. Mustafa receives grants from Novo Nordisk. She receives honoraria for lectures from Astra Zeneca, Novo Nordisk, Zuellig Pharma and Abbott. She receives support for attending meetings from Novo Nordisk and Sanofi. She is an Advisory Board member of Astra Zeneca and Novo Nordisk. She is a Board of Trustee of the National Diabetes Institute (NADI) and a Council Member of the Malaysian Endocrine and Metabolic Society (MEMS).
PROF. THAN THAN AYE | Associate Editor | Prof. Aye has nothing to disclose.
CHAICHARN DEEROCHANAWONG | Associate Editor | Prof. Deerochanawong has nothing to disclose.
NGUYEN THY KHUE |Associate Editor | Prof. Khue receives consulting fees from Merck. She receives honoraria for lectures from Servier, Boehringer Ingelheim and Novo Nordisk. She receives fees as the Advisory Board of Kowa. She is a member of the Vietnamese Association of Diabetes and Endocrinology (VADE), Ho Chi Minh City Association of Diabetes and Endocrinology (HADE) and Ho Chi Minh City Medical Association.
MARY ANN R. ABACAN | Editorial Board Member | Prof. Abacan receives grants as co-investigator of the Registry of Lysosomal Storage Disorders from Sanofi Genzyme (2014 to present) and as co-investigator of the SHP-ELA-401 - A Long-Term, Open-Label, Multicenter, Phase IV Study to Assess Longitudinal Changes on Height and Weight in Patients with MPS II who are receiving Elaprase and started Treatment with Elaprase at <6 Years of Age - Shire (2015-present). She is a Consultant Medical Specialist at the Institute of Human Genetics at the University of the Philippines-National Institutes of Health. She received honoraria as a lecturer of the Training Workshop for Dietitians (Overview of Urea Cycle Disorders). She is a co-chair of the National Transplant Ethics Committee of the Department of Health and the Chair of the Metabolic Experts Panel at the Newborn Screening Reference Center of the National Institutes of Health. She is a stockholder of Clinical Genetics and Genomics Counselling Care Services, Inc. She is the Chair of the Congenital and Developmental Disorders Task Force, Philippine Periodic Health Examination II - Institute of Clinical Epidemiology and DOH joint project (2021), Technical Facilitator of the Pediatric Immunization Task Force, Philippine Periodic Health Examination III - Institute of Clinical Epidemiology and DOH joint project (2023) and a Technical Facilitator of the Dengue Task Force, Philippine Periodic Health Examination III - Institute of Clinical Epidemiology and DOH joint project (2023).
LORNA R. ABAD | Editorial Board Member | Prof. Abad has nothing to disclose.
MARISSA M. ALEJANDRIA | Editorial Board Member | Prof. Alejandria has nothing to disclose.
PIA D. BAGAMASBAD | Editorial Board Member | Prof. Bagamasbad received grant funding from the Department of Science and Technology-Philippine Council for Health Research Development (DOST-PCHRD) to conduct research on prostate cancer and SARS-CoV-2 and the DOST-National Academy of Science and Technology (NAST) to conduct research on prostate cancer. She received honoraria as a plenary speaker of the Philippine College of Endocrinology, Diabetes and Metabolism (PCEDM) and the Philippine Society of Medical Oncology (PSMO). She is a member of the Endocrine (ENDO) Society (no financial involvement).
SARAT SUNTHORNYOTHIN | Editorial Board Member | Prof. Sarat has nothing to disclose.
NATTAPOL SATHAVARODOM | Editorial Board Member | Prof. Nattapol has nothing to disclose.
CHIAW LING CHNG | Editorial Board Member | Dr. Chng has nothing to disclose.
TINT SWE LATT | Editorial Board Member | Prof. Latt has nothing to disclose.
KHOO CHIN MENG | Editorial Board Member | Dr. Meng has nothing to disclose.
NURAIN MOHD NOOR | Editorial Board Member | Dr. Noor is the current President of the Malaysian Endocrine and Metabolic Society (MEMS).
NATHANIEL S. ORILLAZA JR. | Editorial Board Member | Dr. Orillaza receives research grants from the University of the Philippines and the Department of Science and Technology-Philippine Council for Health Research Development (DOST-PCHRD). He receives honoraria for lectures from Viatris, Mundipharma and Menarini. He receives faculty development grants from the University of the Philippines and financial support from Viatris to attend a pain management conference. He applied patents for medical devices at the University of the Philippines. He is a Research Officer of the AO Trauma Philippines, an evidence reviewer of the CPG Development team for the Osteoporosis Society of the Philippines Foundation Inc. (OSPFI) and a Steering Committee member of the CPG Development team for The Philippine Guidelines on Periodic Health Examination for Screening of Musculoskeletal Disorders (PHEX MSK). He is a stockholder of the Tagaytay Medical Center.
PAUL MATTHEW D. PASCO| Editorial Board Member | Dr. Pasco has nothing to disclose.
CATHERINE LYNN T. SILAO| Editorial Board Member | Dr. Silao receives research grants from the Newborn Screening Reference Center and the National Institutes of Health. She receives fees for lectures from the Nestle Nutrition Institute. She received grants from the Asia Pacific Society of Human Genetics. She has pending patents for Methods and Means for Prognosticating the Occurrence of Pulmonary Complications in Leptospirosis and Early Diagnosis and Prognosis of Complicated Leptospirosis using Molecular Markers. She is the Secretary and Board of Directors of the Asia Pacific Society of Human Genetics. She is also a member of the Human Genome Education Committee (no financial involvement). She is a stockholder of the Clinical Genetics and Genomic Counseling Care Services (CGGCCS) Inc.
ROGELIO V. TANGCO | Editorial Board Member | Dr. Tangco has nothing to disclose.
NGUYEN VAN TUAN | Editorial Board Member | Prof. Van Tuan received financial support from the Australian National Health and Medical Research Council for his research. He also received a grant from Amgen to conduct research in osteoporosis. He is a member of Healthy Bone Australia (no financial involvement).
MYO WIN | Editorial Board Member | Prof. Win has nothing to disclose.
MARITA V.T. REYES | Ethics Adviser | Dr. Reyes received a research grant to the Women's Health Care Foundation from the Philippine Council for Health Research and Development. She receives honoraria as a Technical Reviewer of research proposals and as a trainer on research ethics from the Department of Science and Technology-Philippine Council for Health Research Development (DOST-PCHRD). She was also the President and Chair of the Board of Trustees of the Women's Health Care Foundation Incorporated (no financial involvement)
AMADO O. TANDOC III | Editorial Coordinator | Dr. Tandoc receives fees as a Consultant Editor of the Scientific Proceedings of the Lung Center of the Philippines, Philippine Journal of Orthopaedics and the Philippine Journal of Allergy, Asthma and Immunology. He is also the Editor-in-Chief of the Philippine Journal of Pathology. He is a speaker and Treasurer of the Philippine Association of Medical Journal Editors (PAMJE).
